###begin article-title 0
Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
###end article-title 0
###begin p 1
Conceived and designed the experiments: SS PB AR FC MJ. Performed the experiments: SS FC DC WB MJ. Analyzed the data: MF AR FC VP WB. Contributed reagents/materials/analysis tools: OM. Wrote the paper: PB AR.
###end p 1
###begin p 2
Type II hexokinase is overexpressed in most neoplastic cells, and it mainly localizes on the outer mitochondrial membrane. Hexokinase II dissociation from mitochondria triggers apoptosis. The prevailing model postulates that hexokinase II release from its mitochondrial interactor, the voltage-dependent anion channel, prompts outer mitochondrial membrane permeabilization and the ensuing release of apoptogenic proteins, and that these events are inhibited by growth factor signalling. Here we show that a hexokinase II N-terminal peptide selectively detaches hexokinase II from mitochondria and activates apoptosis. These events are abrogated by inhibiting two established permeability transition pore modulators, the adenine nucleotide translocator or cyclophilin D, or in cyclophilin D knock-out cells. Conversely, insulin stimulation or genetic ablation of the voltage-dependent anion channel do not affect cell death induction by the hexokinase II peptide. Therefore, hexokinase II detachment from mitochondria transduces a permeability transition pore opening signal that results in cell death and does not require the voltage-dependent anion channel. These findings have profound implications for our understanding of the pathways of outer mitochondrial membrane permeabilization and their inactivation in tumors.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 222 225 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Wilson1">[1]</xref>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 326 329 326 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
###xml 721 724 721 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
###xml 787 790 787 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Majewski1">[4]</xref>
###xml 792 795 792 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Rathmell1">[5]</xref>
###xml 858 864 858 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino1">[VDAC]</xref>
###xml 866 871 866 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Vyssokikh1">[6,7]</xref>
###xml 948 951 948 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Colombini1">[8]</xref>
###xml 953 956 953 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-ShoshanBarmatz1">[9]</xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Zaid1">[10]</xref>
###xml 1121 1125 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino2">[11]</xref>
###xml 1298 1302 1289 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Juhaszova1">[12]</xref>
Hexokinase (HK) initiates all major pathways of intracellular glucose utilization, and type II HK (HK II) couples glycolysis to oxidative phosphorylation by interacting with mitochondria, thus acting as a metabolic sensor [1]. In highly glycolytic, i.e. extremely aggressive tumours, mitochondrial HK II activity is increased [2] and fosters cell growth in the hypoxic conditions of neoplastic mass accrual by enhancing glycolysis, which becomes independent of oxygen availability (the Warburg effect, 3). Furthermore, mitochondrial HK II plays an important role in maintaining the integrity of the outer mitochondrial membrane (OMM), thus preventing the release of key apoptogenic molecules from the intermembrane space [2]. Reports indicate that nutrients, via the survival kinase Akt [4], [5], promote HK II binding to the voltage-dependent anion channel [VDAC], [6,7], a protein that allows for the movement of small metabolites across the OMM [8], [9]. Release of HK II transmits a potent death signal [10] that is elicited when GSK3beta, a kinase inhibited by Akt, phosphorylates a putative HK docking site on VDAC [11]. However, the role of this pathway remains controversial, as it has been documented that inhibition of GSK-3beta results in GSK-3beta-mediated resistance to oxidant stress [12].
###end p 4
###begin p 5
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Zhou1">[13]</xref>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Majewski1">[4]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino3">[14]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Bernardi1">[15]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Rasola1">[16]</xref>
When associated to HK II, VDAC interacts with antiapoptotic Bcl-2 family members [13]. These might be competed away from VDAC by the pro-apoptotic Bax/Bak proteins after deprivation of growth factors, leading to the formation of a conduit on the OMM fit for the release of apoptogenic proteins [4], [14]. Alternatively, the HK/VDAC interaction could transmit molecular changes to proteins of the inner mitochondrial membrane (IMM), resulting in permeability transition pore (PTP) regulation (reviewed in 2). The PTP is an IMM channel whose opening elicits depolarization, matrix swelling, and consequently cristae unfolding and breaches in the OMM that are pervious to proteins [15], [16].
###end p 5
###begin p 6
A distinction between these two possible scenarios would have important consequences both on the comprehension of apoptosis dysregulation in tumors and on the design of therapeutic approaches targeted to selectively eliminate neoplastic cells. Here, we show that cell death mediated by HK detachment from mitochondria is selectively sensitive to modulators of the PTP. Moreover, we demonstrate that VDAC is dispensable for carrying out this process.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Clotrimazole detaches HK II from mitochondria but displays non-specific effects
###end title 8
###begin p 9
###xml 150 158 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Majewski1">[e.g. 4]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino3">[14]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Machida1">[17]</xref>
###xml 246 255 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1A</xref>
###xml 420 429 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1B</xref>
###xml 264 269 <span type="species:ncbi:9606">human</span>
We initially induced HK II detachment from the OMM with clotrimazole, a drug that efficiently dissociates HK from mitochondria in several cell models [e.g. 4], [14], [17]. As expected, clotrimazole detached HK II from mitochondria of HeLa cells (Figure 1A) and of human T lymphoma Jurkat cells (data not shown). Consistent with published reports, this treatment prompted a marked and concentration-dependent cell death (Figure 1B, upper row).
###end p 9
###begin title 10
Effects of clotrimazole on cells and mitochondria.
###end title 10
###begin p 11
###xml 780 784 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 824 826 816 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1015 1017 1007 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1112 1113 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1167 1169 1159 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1335 1337 1327 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1401 1405 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1614 1616 1606 1608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1745 1747 1737 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1863 1865 1855 1857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 2035 2038 2027 2030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1937 1942 <span type="species:ncbi:10090">mouse</span>
(A) HK II detachment from mitochondria following a 1 hour treatment with clotrimazole (CTM, 20 microM) was assessed by Western immunoblot on a mitochondrial fraction of HeLa cells. The blot was also probed with prohibitin as a mitochondrial marker and with actin as a cytosolic marker (negative, not shown), to check for fraction purity. (B) Output of multiparametric FACS analysis show apoptosis induction of HeLa cells exposed for 2 hours to several concentrations of CTM with or without pre-incubation with Debio 025 (DB, 8 microM). Healthy cells (H) are delimited by the quadrant. Apoptotic cells (A) display mitochondrial depolarization (reduced TMRM staining) and/or expose phosphatidylserine on their surface (increased Annexin V-FITC staining). Propidium iodide-positive, i.e. dead cells (D), were evaluated on a PI vs TMRM diagram (not shown); these cells were excluded from the reported plots and shown as histograms. Numbers are percentages. (C) PTP opening of digitonized HeLa cells measured with the Ca2+ retention capacity assay. Calcium Green-5N fluorescence is reported as arbitrary units on the y axis. As the probe does not permeate mitochondria, Ca2+ uptake into the organelles is displayed by a rapid decrease of the fluorescence spike. Pore inducers or inhibitors reduce or increase, respectively, the threshold Ca2+ concentration required to trigger the permeability transition, i.e. the number of spikes before a sudden and marked fluorescence increase occurs. Experiments were started by the addition of digitonized cells (not shown) followed by pulses of the indicated concentrations of Ca2+. Where indicated, CTM was added to cells 45 minutes before permeabilization with digitonin. Note that CTM reduced the rate of Ca2+ uptake into mitochondria. In the upper right plot DB was added before mitochondria to test the PTP-dependence of Ca2+ release. (D) Respiration assay performed on mitochondria isolated from mouse liver. The graph shows the rate of oxygen consumption (ng AtO stands for ngatoms of oxygen) vs. different concentrations of CTM. The rate of respiration is displayed in basal conditions (blacksquare, square, filled), after ADP administration (*) or after dinitrophenol administration (black triangle). All reported results in the Figure are representative of at least four experiments.
###end p 11
###begin p 12
###xml 272 281 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-trans</italic>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Baines1">[18]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Kokoszka1">[22]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Hansson1">[23]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Angelin1">[24]</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1B</xref>
###xml 817 819 817 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 866 868 866 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 958 960 958 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 991 993 991 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1063 1070 1063 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 1075 1077 1075 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1192 1194 1192 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1308 1310 1308 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1337 1341 1337 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1400 1409 1400 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1C</xref>
###xml 1623 1632 1623 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1D</xref>
###xml 1911 1914 1911 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
We asked whether HK II detachment from the OMM could induce cell death by opening the mitochondrial PTP. The molecular composition of the PTP is at present unsolved. Nonetheless, pharmacological and genetic evidences identify cyclophilin (CyP-D), a matrix peptidyl-prolyl cis-trans isomerase, and the adenine nucleotide translocator (ANT), a carrier that exchanges adenine nucleotides across the IMM, as pore regulators [18]-[22]. Therefore, cells were pretreated with the cyclophilin inhibitor MeAla3EtVal4-cyclosporin (Debio 025), selectively targeting CyP-D in mitochondria, and thereby desensitizing the mitochondrial PTP without inhibiting calcineurin [23], [24]. Remarkably, cell death was fully abrogated (Figure 1B, lower row). We then directly assessed occurrence of PTP opening by measuring the threshold Ca2+ required to open the PTP with the sensitive Ca2+ retention capacity (CRC) test. Permeabilized whole-cells were triggered with trains of Ca2+ pulses in the presence of a Ca2+-sensitive fluorescent probe that does not permeate mitochondria (see Methods). Ca2+ uptake into mitochondria was therefore displayed as a rapid fluorescence drop. When the PTP opened, the ensuing Ca2+ release from mitochondria was assessed as a sudden fluorescence increase. We found that clotrimazole inhibited Ca2+ uptake into mitochondria, i.e. the slope of the fluorescence reduction after each pulse (Figure 1C), and this same effect was also observed in isolated mitochondria (not shown). We also found that clotrimazole dramatically decreased ADP- and uncoupler-stimulated respiration in a concentration-dependent manner (Figure 1D); similar results were obtained if succinate (in the presence of rotenone) rather than glutamate/malate was used as a substrate (not shown). Note that respiration and mitochondrial CRC experiments were performed in organelles from liver, and hepatocytes have virtually no HK II [2]. Thus, clotrimazole inhibited respiration by binding to a molecular target other than HK II, and it appears to be toxic to mitochondria independently of its activity on HK II and/or PTP. As dissecting the pharmacology of clotrimazole was beyond the scope of this study, we achieved HK II detachment from mitochondria with a different strategy.
###end p 12
###begin title 13
A HK II peptide specifically detaches HK II from mitochondria and induces cell death
###end title 13
###begin p 14
###xml 114 117 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Majewski1">[4]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino3">[14]</xref>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-AzoulayZohar1">[25]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Robey1">[26]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino3">[14]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Juhaszova2">[27]</xref>
###xml 868 877 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2A</xref>
###xml 903 904 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 910 911 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 939 948 939 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2A</xref>
###xml 1093 1102 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2B</xref>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Machida1">[17]</xref>
###xml 1311 1320 1311 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2B</xref>
###xml 1663 1672 1663 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2C</xref>
###xml 1732 1741 1732 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2C</xref>
###xml 1939 1941 1939 1941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1996 1998 1996 1998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 2025 2034 2025 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2D</xref>
###xml 2181 2185 2181 2185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 2230 2234 2230 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Postic1">[28]</xref>
###xml 2371 2375 2371 2375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Zorov1">[29]</xref>
###xml 2589 2590 2589 2590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2590 2593 2590 2593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
###xml 2596 2597 2596 2597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2597 2600 2597 2600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
###xml 2788 2797 2780 2789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2E</xref>
###xml 705 710 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2209 2212 <span type="species:ncbi:10116">rat</span>
Peptides corresponding to the N-terminal hydrophobic domain of HK were shown to effectively displace it from VDAC [4], [14], suggesting that the latter is required for HK binding to mitochondria [2], [25], [26]. We reasoned that this approach could avoid the unspecific toxic effects observed with clotrimazole. The commercially available fusion protein Antennapedia-HK II [14] was not suitable for our experiments since it has been recently demonstrated that the internalization domain of the Antennapedia homeoprotein itself exhibits confounding effects on the mitochondrial permeability transition ROS threshold in cardiac myocytes [27]. We therefore linked the N-terminal 15 amino acids of HK II to a HIV-1 TAT sequence to allow its entry into the cell. Treatment of HeLa cells with this oligopeptide, called TAT-HK, efficiently displaced HK II from mitochondria (Figure 2A), and induced cytochrome c (cyt c) release into the cytosol (Figure 2A), a hallmark of mitochondrial apoptosis. TAT-HK also disrupted the interaction between HK II and its reported binding partner on the OMM, VDAC (Figure 2B). However, in keeping with a previous work in which cyclosporin A was used [17], we found that the HK II/VDAC binding could also be abrogated by Debio 025, irrespective of the presence of the TAT-HK peptide (Figure 2B). We excluded the possibility that this effect of Debio 025 was due to inhibition of cytosolic CyP-A, as this protein was not detectable in our mitochondrial preparations (not shown). TAT-HK caused a concentration-dependent apoptosis, whereas a peptide obtained by linking an unrelated sequence to the same TAT motif was totally ineffective (Figure 2C, upper row). Debio 025 abrogated TAT-HK-induced apoptosis (Figure 2C, lower row), indicating that this apoptosis was dependent on PTP opening. Moreover, this treatment elicited PTP opening in permeabilized HeLa cells, as assessed by the reduction of the number of Ca2+ pulses in CRC assays, without affecting the rate of Ca2+ uptake into mitochondria (Figure 2D). To extend these results, the activity of the PTP was assessed in a model of excitable cells with high metabolic demand expressing mostly HK II, i.e. freshly isolated adult rat cardiac myocytes [28]. We previously developed a method that allows precise determination of the PTP sensitivity to oxidant stress in intact cardiac myocytes [29]. These cells turned out to be extremely sensitive to the toxic effect of the peptide. TAT-HK showed a concentration-dependent effect on the ROS threshold for mitochondrial permeability transition (MPT) induction (tMPT). tMPT was significantly decreased in myocytes exposed to >0.1 microM TAT-HK for 1 hr, and 10 microM TAT-HK induced fast collapse of the mitochondrial membrane potential followed by cell death (Figure 2E and data not shown). The control peptide had no effect over the concentration range tested (up to10 microM).
###end p 14
###begin title 15
Selective detachment of HK II from mitochondria induces PTP opening and cell death.
###end title 15
###begin p 16
###xml 225 226 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 918 925 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Fig. 1B</xref>
###xml 989 991 969 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1136 1138 1116 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1297 1299 1269 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1388 1389 1360 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1428 1431 1400 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
###xml 1555 1558 1527 1530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
###xml 1849 1852 1821 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1743 1748 <span type="species:ncbi:10090">mouse</span>
(A) HK II detachment from mitochondria of HeLa cells following a 1-hour treatment with TAT-HK (20 microM). Western immunoblots of a mitochondrial and of a cytosolic fraction show a redistribution of both HK II and cytochrome c into the cytosol. Blots were also probed with prohibitin as a mitochondrial marker and with actin as a cytosolic marker to check for fraction purity. (B) HK II immunoprecipitation in HeLa cells kept in control conditions or treated for 1 hour with Debio 025 (DB, 8 microM), TAT-HK (20 microM), or both. Co-immunoprecipitation of VDAC is shown. (C) Output of multiparametric FACS analyses show apoptosis induction of HeLa cells exposed for 2 hours to a control peptide linked to the TAT sequence (TAT-Ctr, 40 microM) or to the reported concentrations of TAT-HK with or without pre-incubation with Debio 025 (DB, 8 microM). Diagrams and percentages of the different cell populations are as in Fig. 1B. (D) PTP opening of digitonized HeLa cells measured with the Ca2+ retention capacity assay. Experiments were started by the addition of cells (not shown) followed by pulses of the indicated concentrations of Ca2+; where indicated, TAT-HK (30 microM) was added to cells 45 minutes before permeabilization with digitonin. TAT-Ctr (40 microM) did not change the number of Ca2+ pulses (not shown). Calcium Green-5N fluorescence is reported as arbitrary units on the y axis. (E) MPT susceptibility to ROS (tMPT) in intact cardiac myocytes is significantly enhanced by TAT-HK while the negative control peptide TAT-Ctr has no effect. tMPT measurements were performed after 1 hr treatment with peptides. Figure represents four independent experiments with 50-60 cells per groups examined. (F) Respiration assay performed on mouse liver mitochondria. The rate of oxygen consumption (ng AtO stands for ngatoms of oxygen) is plotted vs. different concentrations of the HK peptide. The rate of respiration is displayed in basal conditions (blacksquare, square, filled), after ADP administration (*) or after dinitrophenol administration (black triangle). All reported measures in the Figure are representative of at least four experiments.
###end p 16
###begin p 17
###xml 116 125 116 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g002">Figure 2F</xref>
Unlike clotrimazole, the HK peptide did not affect mitochondrial respiration, as measured on isolated mitochondria (Figure 2F).
###end p 17
###begin title 18
The PTP modulators CyP-D and ANT are involved in TAT-HK-elicited apoptosis
###end title 18
###begin p 19
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Basso1">[19]</xref>
###xml 467 476 467 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g003">Figure 3A</xref>
###xml 666 675 666 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g003">Figure 3B</xref>
###xml 1090 1099 1090 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g004">Figure 4A</xref>
###xml 1218 1227 1218 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g004">Figure 4B</xref>
###xml 1346 1355 1346 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g004">Figure 4C</xref>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
In order to further characterize the molecular events determined by HK displacement from the OMM, we investigated the role of CyP-D, the mitochondrial target of Debio 025. We carried out these studies in immortalized fibroblasts from either wild-type or CyP-D knock-out mice [19] which both express HK II (data not shown). TAT-HK induced cell death in wild-type fibroblasts, and this was fully inhibited either by Debio 025 or by the pan-caspase inhibitor Z.VAD-fmk (Figure 3A). Notably, the peptide was only a weak apoptosis inducer in cells derived from CyP-D knock-out mice, and its limited effect was insensitive to Debio 025 but still inhibitable by Z.VAD-fmk (Figure 3B). The unrelated TAT-linked peptide was again ineffective (data not shown). The mandatory role of CyP-D in apoptosis triggered by HK II detachment was confirmed by direct assessment of pore regulation. In fact, mitochondria obtained from wild-type muscles, which express high levels of HK II bound onto their surface, were highly sensitive to pore opening induced by the peptide in a Debio 025-inhibitable fashion (Figure 4A), whereas PTP opening was not susceptible to the HK II peptide in organelles originated from CyP-D knock-out muscles (Figure 4B). Furthermore, the peptide was completely unable to sensitize the pore in wild-type mitochondria obtained from liver (Figure 4C), in which the HK II level is negligible. These observations consistently indicate that CyP-D plays an important role in PTP opening and apoptosis induction due to selective HK II detachment from mitochondria.
###end p 19
###begin title 20
CyP-D modulates apoptosis triggered by detachment of HK II from mitochondria.
###end title 20
###begin p 21
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppif</italic>
###xml 467 474 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Fig. 1B</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
(A, B) Output of multiparametric FACS analyses show apoptosis induction in fibroblasts obtained either from wild-type mice (A) or from mice in which the Ppif gene encoding for CyP-D was ablated (B). Cells were exposed for 2 hours to the reported concentrations of TAT-HK with or without pre-incubation with Debio 025 (DB, 8 microM) or with a pan-caspase inhibitor (Z.VAD-fmk, 50 microM). Diagrams and percentages of the different cell populations are indicated as in Fig. 1B. All reported measures in the Figure are representative of at least four experiments.
###end p 21
###begin title 22
CyP-D modulates PTP opening triggered by detachment of HK II from mitochondria.
###end title 22
###begin p 23
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 517 518 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 533 535 529 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 819 821 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
CRC experiments were performed on mitochondria isolated from muscle of either wild-type (A) or CyP-D knock-out mice (B), or from liver of wild-type animals (C). Assays were started by the addition of mitochondria followed by pulses of the indicated concentrations of Ca2+; where indicated, the reported concentrations of the HK peptide lacking the TAT sequence and/or Debio 025 (DB, 8 microM) were added to mitochondria 5 minutes before recordings. Calcium Green-5N fluorescence is reported as arbitrary units on the y axis. Total Ca2+ loading required to open the pore is reported for each condition, and all reported results are representative of at least four experiments. Treatment of mitochondria with the control peptide (40 microM) or with a HK peptide harbouring the TAT sequence did not change the number of Ca2+ pulses (not shown). All reported measures in the Figure are representative of at least four experiments.
###end p 23
###begin p 24
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Kokoszka1">[22]</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Halestrap1">[30]</xref>
###xml 808 817 808 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g005">Figure 5A</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Belzacq1">[31]</xref>
###xml 1031 1040 1031 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g005">Figure 5B</xref>
###xml 1100 1101 1100 1101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</sub>
###xml 1102 1103 1102 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
We then asked whether displacement of HK II from mitochondria elicited apoptosis by affecting other pore regulators. Pharmacological ligands of the IMM protein ANT modulate PTP opening, but this effect is lost in mitochondria obtained from ANT knock-out cells. As these mitochondria still undergo the permeability transition [22], ANT is dispensable as a pore component, but it operates as a PTP regulator. In this framework, we reasoned that ANT could funnel a conformational change from HK II on the mitochondrial surface to modulate the pore in the inner membrane. In keeping with the presence of a signal transduced by HK II displacement to pore regulators, we observed through immunoprecipitation experiments that the expected [30] interaction between ANT and CyP-D was disrupted by the TAT-HK peptide (Figure 5A). Remarkably bongkrekate, an ANT ligand that stabilizes it in the "m" conformation and acts as an inhibitor of the PTP [31], abrogated cell death triggered by TAT-HK in wild-type but not in CyP-D-knock-out cells (Figure 5B). The lethal effect of TAT-HK could not be rescued by the FOF1 ATP synthase inhibitor oligomycin, suggesting that the effect of bongkrekate is not secondary to inhibition of ATP synthesis (data not shown).
###end p 24
###begin title 25
ANT modulates apoptosis triggered by detachment of HK II from mitochondria.
###end title 25
###begin p 26
###xml 588 595 584 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Fig. 1B</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
(A) Western blot of ANT immunoprecipitation. Co-immunoprecipitation of CyP-D in wild-type mouse fibroblasts is shown either in control conditions or after a 1 hour treatment with TAT-HK. (B) Output of multiparametric FACS analyses show apoptosis induction in fibroblasts obtained either from wild-type mice (upper row) or from CyP-D knock-out animals (lower row). Cells were exposed for 2 hours to the stated concentrations of TAT-HK with or without a 3 hour pre-incubation with bongkrekate (BK, 100 microM). Diagrams and percentages of the different cell populations are indicated as in Fig. 1B. All reported measures in the Figure are representative of at least four experiments.
###end p 26
###begin title 27
VDAC is dispensable for TAT-HK-elicited apoptosis
###end title 27
###begin p 28
###xml 418 427 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6A</xref>
Following the current model, VDAC phosphorylation by GSK3beta prompts HK II detachment from VDAC and induces apoptosis. This is inhibited by growth factors through Akt-dependent inactivation of GSK3beta. We therefore stimulated HeLa cells with insulin, a powerful Akt inducer, to test whether this could inhibit peptide-mediated apoptosis. Surprisingly, we found that insulin did not affect TAT-HK elicited apoptosis (Figure 6A).
###end p 28
###begin title 29
Neither insulin nor VDAC modulate apoptosis triggered by detachment of HK II from mitochondria.
###end title 29
###begin p 30
###xml 164 173 160 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Figure 1B</xref>
###xml 221 225 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 953 960 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g001">Fig. 1B</xref>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
(A) After 10 minutes of insulin (5 microg/ml) stimulation, HeLa cells were exposed for 2 hours to the reported concentrations of TAT-HK and apoptosis assayed as in Figure 1B. Western immunoblot shows GSK3beta inhibition (i.e. Ser9 phosphorylation) by insulin. (B) HK II and VDAC expression in MEF obtained from either wild-type or VDAC 1/3 knock-out mice were assessed by Western immunoblot. VDAC expression was checked with an anti-VDAC1antibody, protein loading with an anti-actin antibody. (C) Immunoprecipitation of HK II and rehybridization with an anti VDAC2 in VDAC1/3 knock-out MEFs. (D) Output of multiparametric FACS analyses show apoptosis induction in VDAC1/3 knock-out MEFs. Cells were exposed for 1 hour to the stated concentrations of TAT-HK with or without pre-incubation with Debio 025 (DB, 8 microM), bongkrekate (BK, 100 microM) or Z.VAD-fmk (50 microM). Diagrams and percentages of the different cell populations are indicated as in Fig. 1B. (E) Mitochondrial depolarization after cell treatment with TAT-HK (10 microM) with or without pre-incubation with Debio 025 (8 microM), as assessed by decreased TMRM staining by epifluorescence microscopy. All reported measurements are representative of at least four experiments.
###end p 30
###begin p 31
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-ShoshanBarmatz1">[9]</xref>
###xml 297 306 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6B</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Baines2">[32]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-BlachlyDyson1">[33]</xref>
###xml 560 569 560 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6C</xref>
###xml 605 608 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 750 759 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6D</xref>
###xml 932 941 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6D</xref>
###xml 1172 1175 1172 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1297 1306 1297 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001852-g006">Figure 6E</xref>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
To formally clarify whether VDAC is essential for the PTP-opening signal conveyed by HK II displacement, we exploited cells obtained from VDAC knock-out animals. Three distinct VDAC isoforms exist in mammals [9]. We utilized mouse embryo fibroblasts (MEF) obtained from VDAC1/3 knock-out animals (Figure 6B), as triple knock-out mice are not viable [32]. According to reports indicating that HK binding is a specific feature of the VDAC1 isozyme [33], we could not detect any co-immunoprecipitation between the residual VDAC2 isoform and HK II in these cells (Figure 6C). We next addressed whether VDAC1/3-/- cells were protected from the noxious activity of the TAT-HK peptide. To our surprise, VDAC1/3-/- MEFs were highly sensitive to the peptide (Figure 6D) in a concentration-dependent manner (data not shown). We also found that cell death was inhibited by Debio 025, by the pan-caspase inhibitor Z.VAD-fmk and by bongkrekate (Figure 6D). These observations support a model in which HK II displacement from mitochondria triggers a PTP-dependent but VDAC-independent apoptotic cascade. This model is strongly supported by direct measurements of pore opening in VDAC1/3-/- MEFs treated with TAT-HK, where the peptide induced a fast mitochondrial depolarization that was abrogated by Debio 025 (Figure 6E).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Warburg1">[3]</xref>
###xml 602 605 602 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
###xml 112 122 <span type="species:ncbi:111938">gatekeeper</span>
Mitochondrial HK II integrates information from growth factor signalling, and acts as a powerful anti-apoptotic gatekeeper to suppress cell death in conditions of adequate nutrition. This is of pivotal importance in cancer, because neoplastic cells display an aberrant hyper-activation of growth factor-induced metabolic pathways; the related overexpression and activation of HK II on mitochondria confers a competitive edge to the most aggressive cancers by increasing their glycolytic metabolism [3], and thus supporting cell proliferation when the tumour mass outgrows the surrounding blood vessels [2]. It is therefore crucial for anti-neoplastic strategies to dissect in detail the mechanisms by which HK II controls the death/survival rheostat of cells.
###end p 33
###begin p 34
###xml 1304 1308 1304 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Scorrano1">[35]</xref>
In this report, we have confirmed that HK II dissociation from mitochondria is a strong pro-apoptotic stimulus, and established that this form of apoptosis requires opening of the mitochondrial PTP independently of VDAC. This observation has conceptual and therapeutical implications. Loss of mitochondrial membrane integrity constitutes a point of no-return in cell commitment to death. Critical effector mechanisms include loss of ATP production and the eventual release from the mitochondrial intermembrane space of proteins with key functions in cell dismantling. The size of these proteins entails specific forms of OMM permeabilization for their release, whose molecular mechanisms remain controversial. One possibility is the direct formation of large channels on the OMM, composed either by proapoptotic Bcl-2 family proteins, or by association of these proteins with mitochondrial membrane channels; proteins might also be funnelled through lipidic pores. Alternatively, opening of the PTP in the IMM could indirectly induce ruptures in the OMM that are large enough to allow release of apoptogenic protein (reviewed in 16,34). The two mechanisms are not mutually exclusive. For instance, cristae remodelling could be required as a PTP-dependent first step to trigger channel opening on the OMM [35]; and differences in the mode of OMM permeabilization could depend on the cell type, the stress stimulus and the energetic conditions of the cell.
###end p 34
###begin p 35
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Baines1">[18]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Kokoszka1">[22]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Baines2">[32]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Krauskopf1">[36]</xref>
###xml 922 926 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Bernardi1">[15]</xref>
Our data indicate that HK release from the OMM prompts a death stimulus that requires PTP opening. The detailed mechanism cannot be defined at present, as the molecular composition of the PTP remains an unsolved riddle. In fact, all suspected pore components, i.e. CyP-D, VDAC and ANT, underwent a rigorous analysis based on the ablation of their coding genes followed by investigation of PTP properties, and none of them turned out to be part of the pore, even if ANT and CyP-D are PTP regulators [18]-[22], [32], [36]. Here, we found that both ANT and CyP-D are key regulators of apoptosis induced by mitochondrial HK II displacement. Treatment with the TAT-HK peptide disrupts the interaction between ANT and CyP-D, suggesting that HK II partitioning away from mitochondria propagates a conformational change directed from molecules associated to the OMM towards structures of the inner membrane, where the PTP resides [15]. This might trigger PTP opening, resulting in the release of apoptogenic proteins and in cell death.
###end p 35
###begin p 36
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Mathupala1">[2]</xref>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Majewski1">[4]</xref>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 910 914 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Pastorino2">[11]</xref>
Our results challenge the view that VDAC is the mitochondrial determinant of cell survival or death, acting as a hub that binds either anti- or pro-apoptotic Bcl-2 family members depending on the presence or absence of HK II, respectively [2]. This model did not explain how HK dissociation from mitochondria could induce OMM permeabilization even in the absence of Bax and Bak [4]. Here we demonstrate that HK II/VDAC binding is also disrupted in conditions that do not promote cell death, i.e. following treatment with Debio 025. More importantly, in cells lacking both VDAC1 and VDAC3, no binding between HK II and the residual VDAC2 could be detected, yet displacement of HK II from mitochondria prompted massive cell death. In addition, the interaction between VDAC and HK II was reported to be inhibited by GSK3beta-mediated VDAC phosphorylation, and stimulated by Akt-dependent inactivation of GSK3beta [11], and this would protect from cell death. However, we found that treating cells with insulin, a powerful Akt activator, cells were not protected from apoptosis elicited by mitochondrial HK II displacement. Again, these results argue against a mandatory cell survival role of a transduction pathway that should convey signals to VDAC. Thus, VDAC appears to be dispensable for cell death elicited by HK II detachment from mitochondria, while resistance to cell death in highly glycolytic tumors appears to be critically dependent on preventing opening of the mitochondrial PTP.
###end p 36
###begin title 37
Materials and Methods
###end title 37
###begin title 38
Chemicals, antibodies and cells
###end title 38
###begin p 39
###xml 890 891 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 992 993 992 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1178 1181 1178 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1174 1181 1174 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppif<sup>&#8722;/&#8722;</sup></italic>
###xml 1245 1248 1245 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1238 1248 1238 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDAC1/3<sup>&#8722;/&#8722;</sup></italic>
###xml 1281 1285 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Wu1">[37]</xref>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
###xml 617 623 <span type="species:ncbi:9986">rabbit</span>
###xml 692 696 <span type="species:ncbi:9925">goat</span>
###xml 763 768 <span type="species:ncbi:10090">mouse</span>
###xml 857 862 <span type="species:ncbi:10090">mouse</span>
###xml 964 970 <span type="species:ncbi:9986">rabbit</span>
###xml 1117 1121 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1188 1193 <span type="species:ncbi:10090">mouse</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
FITC-conjugated Annexin-V was from Boehringer Mannheim (Indianapolis, IN); Calcium Green-5N and tetramethylrhodamine methyl ester (TMRM) were from Molecular Probes (Eugene, OR); the caspase inhibitor Z.VAD-fluoro-methyl-ketone (Z.VAD-fmk) was from Bachem (Subendorf, Switzerland); all other chemicals were from Sigma (St. Louis, MO). Debio 025 was a generous gift of Debiopharm (Lausanne, Switzerland). The mouse monoclonal anti-prohibitin antibody was from Lab Vision (Fremont, CA); the mouse monoclonal anti-actin antibody was from Sigma; the monoclonal anti-CyP-D antibody was from Calbiochem (San Diego, CA); the rabbit polyclonal anti VDAC1 antibody was from Abcam, (Cambridge, UK); the goat polyclonal anti HK II, anti VDAC2 and anti ANT antibodies and the mouse monoclonal anti GSK-3 antibody were from Santa Cruz Biotechnology (Santa Cruz, CA); the mouse monoclonal anti-cytochrome c antibody was from Becton Dickinson Pharmingen (Franklin Lakes, NJ); the rabbit monoclonal anti Bcl-XL and anti phospho Ser-GSK-3 antibodies were from Cell Signaling (Beverly, MA). Diaphragm adult fibroblasts were obtained by SV40 immortalization of primary cells from wild-type and Ppif-/- mice; mouse embryo fibroblasts (MEF) from wild-type and VDAC1/3-/- mice were obtained as described [37]. Apoptosis inducers were added to exponentially growing cells in the absence of serum. Chemical inhibitors of caspases, CyP-D or ANT were added three hours before starting apoptosis induction. As in the following, each experiment was repeated at least four times.
###end p 39
###begin title 40
Flow cytometry analysis of apoptosis induction
###end title 40
###begin p 41
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Gramaglia1">[38]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Rasola2">[39]</xref>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Flow cytometry recordings of apoptotic changes were performed as described [38], [39]. Briefly, after induction of apoptosis, cells were resuspended in 135 mM NaCl, 10 mM HEPES, 5 mM CaCl2 and incubated for 15 min at 37degreesC in FITC-conjugated Annexin-V, TMRM (200 nM) and propidium iodide (PI, 1 microg/ml), to detect mitochondrial depolarization (reduced TMRM staining), phosphatidylserine exposure on the cell surface (increased FITC-conjugated Annexin-V staining), and loss of plasma membrane integrity (PI permeability and staining). Samples were analyzed on a FACSCalibur flow cytometer (Becton Dickinson, San Diego, CA, USA). Data acquisition was performed using CellQuest software and data analysis with WinMDI software. Each experiment was repeated at least four times, and consistency of data allowed to show one representative experiment for each condition.
###end p 41
###begin title 42
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Isolation of mouse mitochondria
###end title 42
###begin p 43
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppif<sup>&#8722;/&#8722;</sup></italic>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Basso1">[19]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Fontaine1">[40]</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Mitochondria were isolated from livers and muscles of wild-type and Ppif-/- C57BL/6 mice [19] through sequential centrifugations, as described [40]. All procedures were carried out at 0-4degreesC.
###end p 43
###begin title 44
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Measurement of mitochondrial Ca2+ retention capacity
###end title 44
###begin p 45
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Fontaine1">[40]</xref>
###xml 177 179 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 224 227 209 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">exc</sub>
###xml 243 245 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">em</sub>
###xml 564 565 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
The Ca2+ retention capacity (CRC) assay was used to assess PTP opening following trains of Ca2+ pulses [40] and measured fluorimetrically at 25degreesC in the presence of the Ca2+ indicator Calcium Green-5N (1 microM; lambdaexc: 505 nm; lambdaem: 535 nm; Molecular Probes). We performed CRC experiments either on isolated mitochondria or on whole cells placed in an isotonic buffer (130 mM KCl, 1 mM Pi-Tris, 10 mM Tris/MOPS, 1 mM EGTA/Tris, pH 7.4) in the presence of 2 microM rotenone/5 mM succinate or 250 mM glutamate/125 mM malate and of 10 microM cytochrome c. Whole cell CRC was carried out after plasma membrane permeabilization with the non-ionic detergent digitonin, which is highly selective for cholesterol-enriched membranes and does not damage mitochondrial membranes. Cells were washed twice in a buffer composed of 130 mM KCl, 10 mM Tris/MOPS, 1 mM Pi-Tris, 1 mM EGTA/Tris, pH 7.4, and then incubated with 50-150 microM digitonin (depending on the cell type) for 15 min at 4degreesC. Digitonin was then washed away by spinning cells twice in a cytosolic-like solution (130 mM KCl, 10 mM Tris/MOPS, 1 mM Pi-Tris, 0.1 mM EGTA/Tris, pH 7.4), and the number of cells carefully assessed before starting each experiment.
###end p 45
###begin title 46
Mitochondrial respiration assay
###end title 46
###begin p 47
Mitochondrial oxygen consumption was measured polarographically at 25degreesC with a Clark oxygen electrode (Yellow Springs Instruments, OH, USA). Mitochondria were incubated in a solution of 130 mM KCl, 10 mM Tris-Mops, 1 mM Pi-Tris, 20 microM EGTA-Tris and 250 mM glutamate/125 mM malate or 2 microM rotenone/5 mM succinate to assay basal respiration (state 4). ADP (200 microM) was subsequently added to measure state 3 respiration, followed by the uncoupling agent dinitrophenol (DNP, 100 microM) to assess the maximal respiration rate.
###end p 47
###begin title 48
Cell lysis, fractionation and Western immunoblot analysis
###end title 48
###begin p 49
###xml 95 96 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 314 315 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 954 965 <span type="species:ncbi:3704">horseradish</span>
Total cell extracts were prepared at 4degreesC in 135 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 mM CaCl2, 1% NP40 or 1% Triton X-100 in the presence of phosphatase and protease inhibitors. To prepare mitochondrial extracts, cells were placed cells in a hypotonic solution (10 mM Tris-HCl pH 7.6, 10 mM KCl, 150 microM MgCl2) and homogenized at 4degreesC. Mitochondria were then isolated by differential centrifugation. For immunoprecipitations, 1000-1500 microg of proteins per reaction were incubated with antibodies conjugated to protein A- or protein G-Sepharose beads (Pharmacia, Pfizer, Cambridge, MA) at 4degreesC overnight. Negative controls were performed by incubating lysates on conjugated beads in the absence of primary antibodies. Samples were then separated in reducing conditions on SDS-polyacrylamide gels and transferred onto Hybond-C Extra membranes (Amersham, Little Chalfont, UK). Primary antibodies were incubated 16 hours at 4degreesC, and horseradish peroxidase-conjugated secondary antibodies were added for 1 hour. Proteins were visualized by enhanced chemiluminescence (Amersham).
###end p 49
###begin title 50
Peptide synthesis
###end title 50
###begin p 51
###xml 291 295 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Fields1">[41]</xref>
Peptides MIASHLLAYFFTELNbetaA-GYGRKKRRQRRRG (TAT-HK) and GYGRKKRRQRRRG-betaA-EEEAKNAAAKLAVEILNKEKK (TAT-Ctr) were synthesized by a solid phase method using an automatized peptide synthesizer (model 431-A, Applied Biosystems, Foster City, CA). The fluoren-9-ylmethoxycarbonyl (Fmoc) strategy [41] was used throughout the peptide chain assembly, utilizing 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) and 1-hydroxybenzotriazole (HOBt) as coupling reagents. HMPA PEGA resin (Novabiochem, Bad Soden, Germany) was used as solid support. The side-chain protected amino acid building blocks used were: Fmoc-Tyr(tert-butyl), Fmoc-Glu(tert-butyl), Fmoc-Ser(tert-butyl), Fmoc-Thr(tert-butyl), Fmoc-Lys(tert-butyloxycarbonyl), Fmoc-His(trityl), Fmoc-Asn(trityl), Fmoc-Gln(trityl), and Fmoc-Arg(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl). Cleavage of the peptides was performed by reacting the peptidyl-resins with a mixture containing TFA/H20/thioanisole/ethanedithiol/phenol (10 ml/0.5 ml/0.5 ml/0.25 ml/750 mg) for 2.5 h. Crude peptides were purified by a preparative reverse phase HPLC. Molecular masses of the peptides were confirmed by mass spectroscopy with direct infusion on a Micromass ZMD-4000 Mass Spectrometer (Waters-Micromass). The purity of the peptides was about 95% as evaluated by analytical reverse phase HPLC.
###end p 51
###begin title 52
Mitochondrial membrane potential assay
###end title 52
###begin p 53
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Angelin1">[24]</xref>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Petronilli1">[42]</xref>
###xml 556 557 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
This was measured in the presence of 20 nM TMRM as described elsewhere [24], [42]. Fluorescent images were acquired with an Olympus (Center Valley, PA) IX71/IX51 inverted microscope equipped with a xenon light source and with a 12-bit digital cooled charge-coupled device (CCD) camera (Micromax, Princeton Instruments, Trenton, NJ). For detection of fluorescence, 568 +/- 25-nm bandpass excitation and 585-nm longpass emission filter settings were used. Images were collected with an exposure time of 100 msec. Data were acquired and analyzed by using CellR software (Olympus). Clusters of 10-30 mitochondria were acquired every 2 min, and fields not containing cells were taken as the background.
###end p 53
###begin title 54
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 77 80 77 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
Determination of mitochondrial permeability transition (MPT) ROS threshold (tMPT)
###end title 54
###begin p 55
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Juhaszova1">[12]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001852-Zorov1">[29]</xref>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 706 707 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 707 710 695 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPT</sub>
Cardiac myocyte isolation, confocal microscopy and determination of MPT ROS threshold have been described [12], [29]. Briefly, isolated myocytes loaded with 125 nM TMRM were exposed in vitro to conditions that mimic oxidative stress by repetitive laser line-scanning of a row of approximately25 mitochondria at 2 Hz with an LSM-510 confocal microscope (Carl Zeiss Inc., Jena, Germany) with excitation at 543nm and collecting emission at >560 nm using a 63x/1.4 oil immersion objective. This results in controlled, incremental photodynamic production of ROS in the scanned area with consequent MPT induction. MetaMorph image analysis software (Molecular Devices Corp., Downingtown PA) was used to calculate tMPT and was defined as average time required to induce MPT in targeted mitochondria.
###end p 55
###begin p 56
We thank Davide Bartoli for technical assistance, Luca Scorrano for providing the immortalized CyP-D knock-out fibroblasts, William J. Craigen for providing the immortalized VDAC knock-out fibroblasts and Debiopharm SA, Lausanne, for the gift of Debio 025.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function.
###end article-title 58
###begin article-title 59
###xml 74 84 <span type="species:ncbi:111938">gatekeeper</span>
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.
###end article-title 59
###begin article-title 60
On the origin of cancer cells.
###end article-title 60
###begin article-title 61
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.
###end article-title 61
###begin article-title 62
Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.
###end article-title 62
###begin article-title 63
Hexokinase II: the integration of energy metabolism and control of apoptosis.
###end article-title 63
###begin article-title 64
VDAC and peripheral channelling complexes in health and disease.
###end article-title 64
###begin article-title 65
VDAC: the channel at the interface between mitochondria and the cytosol.
###end article-title 65
###begin article-title 66
The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death.
###end article-title 66
###begin article-title 67
The voltage-dependent anion channel-1 modulates apoptotic cell death.
###end article-title 67
###begin article-title 68
Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.
###end article-title 68
###begin article-title 69
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.
###end article-title 69
###begin article-title 70
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
###end article-title 70
###begin article-title 71
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.
###end article-title 71
###begin article-title 72
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The mitochondrial permeability transition from in vitro artifact to disease target.
###end article-title 72
###begin article-title 73
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis.
###end article-title 73
###begin article-title 74
Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells.
###end article-title 74
###begin article-title 75
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.
###end article-title 75
###begin article-title 76
Properties of the permeability transition pore in mitochondria devoid of cyclophilin D.
###end article-title 76
###begin article-title 77
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.
###end article-title 77
###begin article-title 78
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.
###end article-title 78
###begin article-title 79
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore.
###end article-title 79
###begin article-title 80
The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria.
###end article-title 80
###begin article-title 81
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins.
###end article-title 81
###begin article-title 82
In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.
###end article-title 82
###begin article-title 83
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.
###end article-title 83
###begin article-title 84
The identity and regulation of the mitochondrial permeability transition pore: Where the known meets the unknown.
###end article-title 84
###begin article-title 85
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Development and regulation of glucose transporter and hexokinase expression in rat.
###end article-title 85
###begin article-title 86
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.
###end article-title 86
###begin article-title 87
Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
###end article-title 87
###begin article-title 88
The adenine nucleotide translocator in apoptosis.
###end article-title 88
###begin article-title 89
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.
###end article-title 89
###begin article-title 90
###xml 37 42 <span type="species:ncbi:4932">yeast</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel.
###end article-title 90
###begin article-title 91
Regulation of cell death: the calcium-apoptosis link.
###end article-title 91
###begin article-title 92
A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis.
###end article-title 92
###begin article-title 93
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
Properties of the permeability transition in VDAC1-/- mitochondria.
###end article-title 93
###begin article-title 94
Each mammalian mitochondrial outer membrane porin protein is dispensable: effects on cellular respiration.
###end article-title 94
###begin article-title 95
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-XL- and PKB/AKT-independent fashion.
###end article-title 95
###begin article-title 96
A flow cytometry assay simultaneously detects independent apoptotic parameters.
###end article-title 96
###begin article-title 97
Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex I.
###end article-title 97
###begin article-title 98
Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.
###end article-title 98
###begin article-title 99
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was made possible by grants from the Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita' e della Ricerca (MIUR-PRIN, to P.B.), from the USA NIH-PHS (Grant GM69883 to M.F and P.B.), from the Intramural Research Program, National Institute on Aging, NIH (to M.J. and S.J.S.), from AIRC (to P.B.), and from Progetti di Ateneo dell'Universita di Padova (to A.R.).
###end p 101

